SEC Form 3 · accession 0001209191-19-004543
PULSE BIOSCIENCES, INC. · PLSE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ed Ebbers
Officer — EVP & GM, Dermatology
Period of report
Jan 11, 2019
Accepted (ET)
Jan 18, 2019 · 4:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001625101
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 40,376 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $4.68 | holding | — | — | — | — | Jul 13, 2026 | Common Stock | 56,159 | — | D |
| Stock Option (right to buy)F3 | $27.14 | holding | — | — | — | — | Feb 15, 2027 | Common Stock | 30,000 | — | D |
Explanation of responses
- F110,863 shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer. Fifty percent (50%) of the RSUs will vest on June 1, 2019 and the remaining 50% will vest on June 1, 2021, subject to the Reporting Person's continued service through each vesting date.
- F2The original option was for 117,200 shares. The remaining unexercised shares subject to the option will vest in equal monthly installments and will be fully vested on July 11, 2020, subject to the Reporting Person's continued service through each vesting date.
- F3The shares subject to the option will vest in equal monthly installments over a four year period that began on February 15, 2017, subject to the Reporting Person's continued service through each vesting date.